Proceedings Paper
Flow Cytometric Changes That Precede Cancer: Premalignant Gastrointestinal Disease| Format | Member Price | Non-Member Price |
|---|---|---|
| $17.00 | $21.00 |
Paper Abstract
Abnormalities in cellular DNA content and proliferative rate are observed not only in cancer, but may be seen in premalignant disease as part of the multistep process of progression towards malignancy during carcinogenesis. Flow cytometry can be used to document these premalignant changes. Several gastrointestinal diseases provide good models for studying these abnormalities as early detectors which may select those patients at greatest risk for progression to cancer.
Paper Details
Date Published: 13 June 1989
PDF: 10 pages
Proc. SPIE 1063, New Technologies in Cytometry, (13 June 1989); doi: 10.1117/12.951906
Published in SPIE Proceedings Vol. 1063:
New Technologies in Cytometry
Gary C. Salzman, Editor(s)
PDF: 10 pages
Proc. SPIE 1063, New Technologies in Cytometry, (13 June 1989); doi: 10.1117/12.951906
Show Author Affiliations
P. S Rabinovitch, University of Washington (United States)
G. C. Burmer, University of Washington (United States)
R. C. Haggitt, University of Washington (United States)
G. C. Burmer, University of Washington (United States)
R. C. Haggitt, University of Washington (United States)
D. S Levine, University of Washington (United States)
C. E. Rubin, University of Washington (United States)
B. J. Reid, University of Washington (United States)
C. E. Rubin, University of Washington (United States)
B. J. Reid, University of Washington (United States)
Published in SPIE Proceedings Vol. 1063:
New Technologies in Cytometry
Gary C. Salzman, Editor(s)
© SPIE. Terms of Use
